More Business Wire
View Older Stories View Newer Stories-
Alzheon Announces that United States Federal Circuit Affirmed Decision of U.S. Patent Office Invalidating Risen (Suzhou) Pharmaceutical Technology Co., Ltd.’s Patent on Isotopically Enriched Forms o
-
Quincy Data Distributes the Lowest Latency Market Data Between New Jersey and Toronto-TMX
-
Sign Up for an Introductory Class with Body & Brain Yoga Tai Chi
-
Exact Sciences Schedules First Quarter 2024 Earnings Call
-
Japanese fragrance AI service SCENTMATIC KAORIUM, selected as lifestyle trend 2023 in global digital magazine STIR
-
Expro Report Highlights Progress Unlocking Energy Answers of Tomorrow
-
Quectel to Showcase Latest IoT Solutions at Embedded World 2024
-
Spring Investments SA Appoints Jackie Ineke as New Chief Investment Officer
-
Air Liquide: Voting Rights
-
Imagination’s New Catapult CPU Is Driving RISC-V Device Adoption
-
United States: TotalEnergies Expands its Natural Gas Production in Texas
-
SHL Telemedicine’s SmartHeart® Technology Triumphs in US Army Project Convergence – Capstone 4 Experiment
-
Joint Statement of the Independent State of Papua New Guinea and TotalEnergies
-
Asian Productivity Organization Awards Outstanding Productivity Champions
-
Ashling Announces Support for Altera’s Agilex™ 5 FPGA Family in their RiscFree™ SDK and Toolchain
-
ViroCell to present at 2024 Cell & Gene Meeting on the Med
-
UMC Reports Sales for March 2024
-
Juniper Research: Travel eSIM Users to Grow 440% Globally Over the Next 5 Years; Disrupting Traditional Roaming Market
-
Sensorion Announces a €15 Million Financing, Extending Cash Runway Until the End of 2025
-
Pan American Silver reports additional high-grade drill results from the La Colorada Skarn project
-
Efinix’s Titanium Ti375 Sampling; Unlocking and Delivering Mainstream Edge Intelligence Innovation
-
Indian Motorcycle Dealers Ranked Highest in 2024 Industry Study Measuring Response to Website Customers
-
Accenture to Acquire CLIMB to Expand Technology Capabilities
-
Yinhawangka People and Rio Tinto partner to co-design ‘Living Cultures Program’
-
APR.TW Makes Donations to Help Earthquake Victims in Taiwan
-
Rio Tinto appoints Bold Baatar as Chief Commercial Officer
-
Update on Internal Matters at AnalytixInsight
-
Alcon Publishes Agenda for 2024 Annual General Meeting
-
Affini-T Therapeutics Presents Preclinical Data from its Oncogenic Driver Programs Targeting KRAS G12D and p53 R175H at the American Association for Cancer Research (AACR) Annual Meeting 2024
-
Edgewood Oncology Announces Positive Efficacy Data From Investigator-Sponsored Study of BTX-A51 in Preclinical Models of Liposarcoma
-
Study of NFL Alumni Cohort Finds Majority Suffer From Heart Disease Without Knowing It
-
Ribometrix Presents First c-MYC Data Validating RNA-Targeting Platform and Demonstrates Synergistic Potential of eIF4E Program at AACR 2024
-
Notice of Injunction Prohibiting Hytera From Selling or Distributing Any Products Containing Two-Way Radio Technology
-
Arrowhead Pharmaceuticals Announces New Phase 2 Data of Plozasiran Published in JAMA Cardiology and Presented at American College of Cardiology 73rd Annual Scientific Session & Expo
-
CorVista Health to Present New Data on the Use of Machine Learning as a Non-Invasive Point-of-Care Rule-out Test for Heart Failure at ACC 2024
-
Alnylam Presents Positive Results from the KARDIA-2 Phase 2 Study of Zilebesiran Added to Standard of Care Antihypertensives in Patients with Inadequately Controlled Hypertension
-
Angelalign Announces Solid Progress in 2023
-
egnite, Inc. and JenaValve Announce Novel Research on Outcomes with Untreated Aortic Regurgitation at the 2024 American College of Cardiology Conference
-
Bristol Myers Squibb Presents New Pooled Interim Long-Term Safety and Metabolic Outcomes Data from the EMERGENT Program Evaluating KarXT in Schizophrenia at the 2024 Annual Congress of the Schizophr
-
Bristol Myers Squibb Presents New Interim Long-Term Efficacy Data from the EMERGENT-4 Trial Evaluating KarXT in Schizophrenia at the 2024 Annual Congress of the Schizophrenia International Research So
-
New Pharmacokinetic Modeling Data Presented by Teva Simulates Clinical Profiles of Schizophrenia Patients Switching to UZEDY® (risperidone) Extended-Release Injectable Suspension at SIRS 2024
-
Wipro Appoints Srini Pallia as CEO & Managing Director
-
The United States Army and United Football League Announce Exclusive Partnership; U.S. Army Becomes the Presenting Partner of the UFL
-
Tempus Introduces Workspaces into its Lens Data Analytics Platform
-
Legend Biotech’s CARVYKTI® (ciltacabtagene autoleucel) Becomes the First and Only BCMA-Targeted CAR-T Cell Therapy Approved by the FDA for Second-Line Treatment of Multiple Myeloma
-
ENHERTU® Approved in the U.S. as First Tumor Agnostic HER2 Directed Therapy for Previously Treated Patients with Metastatic HER2 Positive Solid Tumors
-
Avangrid Statement on Gas Subsidiaries’ Response to 4.8 Magnitude Earthquake
-
ENHERTU® (fam-trastuzumab deruxtecan-nxki) approved in the US as first tumor-agnostic HER2-directed therapy for previously treated patients with metastatic HER2-positive solid tumors
-
Herbalife Expects to Complete $1.6 Billion Secured Refinancing on April 12
-
Herbalife Announces Pricing of Upsized $800 Million Aggregate Principal Amount of Senior Secured Notes Offering
